IJCM  Vol.7 No.9 , September 2016
The Number of Lymph Nodes and Relationship with Presence of Thyroiditis and Thymic Tissue in the Central Neck Dissection Materials for Thyroid Papillary Carcinoma: Pathologic Analysis
Abstract: Background: Central lymph node dissection (CLND) for papillary thyroid carcinoma (PTC) allows correct pathologic staging of lymph nodes and planning of postoperative management. The purpose of this study was to determine the number of the lymph nodes in the CLND and the relationship to presence of chronic lymphocytic thyroiditis (CLT) and thymic tissue (TT). Methods: Total thyroidectomy and CLND materials from 153 patients with PTC were included in this study. Two histopathologic features (presence of CLT and TT) were evaluated for their value in adequacy of CLND. Results: Histopathologic examination revealed CLT and TT in CLND materials in 70 (46%) and 63 (41%) patients, respectively. Total number of lymph nodes in CLND materials was significantly higher in CLT (+) and TT (+) groups (p < 0.001), independently. LN metastases in central compartment were found in 40% of patients (n = 61). Of these, 30 patients had underlying CLT. The metastatic LN ratio (metastatic LN/total LN) was significantly lower in CLT (+) group, comparing to CLT (-) group (16.8% ± 12.2% vs 46.4% ± 27.5%; p < 0.001). Conclusions: Our study demonstrates that presence of CLT in thyroid gland has been associated with higher number of central lymph nodes mainly due to increased number of benign hyperplastic lymph nodes. It may be possible to conclude that upper limit of lymph nodes for satisfactory CLND would be higher to correctly evaluate central lymph node status in existing staging systems if specimens have CLT. Results of this study also show that the presence of TT in surgical materials may represent the adequacy of CLND.
Cite this paper: Bilezikçi, B. , Ilgan, S. , Özbaş, S. and Koçak, S. (2016) The Number of Lymph Nodes and Relationship with Presence of Thyroiditis and Thymic Tissue in the Central Neck Dissection Materials for Thyroid Papillary Carcinoma: Pathologic Analysis. International Journal of Clinical Medicine, 7, 566-576. doi: 10.4236/ijcm.2016.79062.

[1]   Fritze, D. and Doherty, G.M. (2010) Surgical Management of Cervical LNs in Differentiated Thyroid Cancer. Otolaryngologic Clinics of North America, 43, 285-300.

[2]   Sywak, M., Cornford, L., Roach, P., Stalberg, P., Sidhu, S. and Delbridge, L. (2006) Routine Ipsilateral Level VI Lymphadenectomy Reduces Postoperative Thyroglobulin Levels in Papillary Thyroid Cancer. Surgery, 140, 1000-1005; Discussion, 1005-1007.

[3]   Lundgren, C.I., Hall, P., Dickman, P.W. and Zedenius, J. (2006) Clinically Significant Prognostic Factors for Differentiated Thyroid Carcinoma: A Population-Based, Nested Case-Control Study. Cancer, 106, 524-531.

[4]   Lee, J., Song, Y., Soh, E.Y. (2014) Central lymph Node Metastasis Is an Important Prognostic factor in Patients with Papillary Thyroid Microcarcinoma. Journal of Korean Medical Science, 29, 48-52.

[5]   Stulak, J.M., Grant, C.S., Farley, D.R., et al. (2006) Value of Preoperative Ultrasonography in the Surgical Management of Initial and Reoperative Papillary Thyroid Cancer. Archives of Surgery, 141, 489-494.

[6]   LiVolsi, V.A. and Baloch, Z.W. (2012) On Pathology Reports of Thyroid Cancer Specimens: What Should the Clinician Expect? Thyroid, 22, 563-565.

[7]   Scherl, S., Mehra, S., Clain, J., et al. (2014) The Effect of Surgeon Experience on the Detection of Metastatic Lymph Nodes in the Central Compartment and the Pathologic Features of Clinically Unapparent Metastatic Lymph Nodes: What Are We Missing When We Don’t Perform Prophylactic Dissection Of Central Compartment Lymph Nodes in Papillary Thyroid Cancer. Thyroid, 24, 1282-1288.

[8]   Pai, S.I. and Tufano, R.P. (2008) Central Compartment Neck Dissection for Thyroid Cancer. Technical considerations. ORL Journal for Otorhinolaryngology and Its Related Specialties, 70, 292-297.

[9]   Lang, B.H., Yih, P.C., Shek, T.W., Wan, K.Y., Wong, K.P. and Lo, C.Y. (2012) Factors Affecting the Adequacy of Lymph Node Yield in Prophylactic Unilateral Central Neck Dissection for Papillary Thyroid Carcinoma. Journal of Surgical Oncology, 106, 966-971.

[10]   Son, Y.I., Jeong, H.S., Baek, C.H., et al. (2008) Extent of Prophylactic Lymph Node Dissection in the Central Neck Area of the Patients with Papillary Thyroid Carcinoma: Comparison of Limited versus Comprehensive Lymph Node Dissection in a 2-Year Safety Study. Annals of Surgical Oncology, 15, 2020-2026.

[11]   Parkash, V., Bifulco, C., Feinn, R., Concato, J. and Jain, D. (2010) To Count and How to Count, That Is the Question Interobserver and Intraobserver Variability among Pathologists in Lymph Node Counting. American Journal of Clinical Pathology, 134, 42-49.

[12]   AJCC Cancer Staging Manual. Springer, New York, 2010.

[13]   Choi, J.S., Kim, J., Kwak, J.Y., Kim, M.J., Chang, H.S. and Kim, E.K. (2010) Preoperative Staging of Papillary Thyroid Carcinoma: Comparison of Ultrasound Imaging and CT. American Journal of Roentgenology, 193, 871-878.

[14]   Shimamoto, K., Satake, H., Sawaki, A., Ishigaki, T., Funahashi, H. and Imai, T. (1998) Preoperative Staging of Thyroid Papillary Carcinoma with Ultrasonography. European Journal of Radiology, 29, 4-10.

[15]   Bonnet, S., Hartl, D., Leboulleux, S., et al. (2009) Prophylactic Lymph Node Dissection for Papillary Thyroid Cancer Less than 2 cm: Implications for Radioiodine Treatment. The Journal of Clinical Endocrinology & Metabolism, 94, 1162-1167.

[16]   Alzahrani, A.S., Raef, H., Sultan, A., et al. (2002) Impact of Cervical Lymph Node Dissection on Serum TG and the Course of Disease in TG-Positive, Radioactive Iodine Whole Body Scan-Negative Recurrent/Persistent Papillary Thyroid Cancer. Journal of Endocrinological Investigation, 25, 526-531.

[17]   Jeon, M.J., Yoon, J.H., Han, J.M., et al. (2013) The Prognostic Value of the Metastatic Lymph Node Ratio and Maximal Metastatic Tumor Size in Pathological N1a Papillary Thyroid Carcinoma. European Journal of Endocrinology, 168, 219-225.

[18]   Kim, M.K., Mandel, S.H., Baloch, Z., et al. (2004) Morbidity Following Central Compartment Reoperation for Recurrent or Persistent Thyroid Cancer. Archives of Otolaryngology—Head and Neck Surgery, 130, 1214-1216.

[19]   Cooper, D.S., Doherty, G.M., Haugen, B.R., et al. (2009) Revised American Thyroid Association ManagementGuidelines for Patients with Thyroid Nodulesand Differentiated Thyroid Cancer. The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 19, 1167-1214.

[20]   Fu, J.Y., Wu, Y., Wang, Z.Y., An, Y., Sun, T.Q. and Xiang, J. (2007) Clinical and Pathological Analysis of Central Compartment Dissection in Patients with Papillary Thyroid Cancer with Negative Clinical Lymph Node Metastasis. Chinese Journal of Surgery, 45, 470-472.

[21]   Pereira, J.A., Jimeno, J., Miquel, J., et al. (2005) Nodal Yield, Morbidity, and Recurrence after Central Neck Dissection for Papillary Thyroid Carcinoma. Surgery, 138, 1095-1100.

[22]   Zeng, R.C., Zhang, W., Gao, E.L., Cheng, P., Huang, G.L., Zhang, X.H. and Li, Q.H. (2014) Number of Central Lymph Node Metastasis for Predicting Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. Head & Neck, 36, 101-106.

[23]   Hartl, D.M., Leboulleux, S., Al Ghuzlan, A., et al. (2012) Optimization of Staging of the Neck with Prophylactic Central and Lateral Neck Dissection for Papillary Thyroid Carcinoma. Annals of Surgery, 255, 777-783.

[24]   Tavares, M.R., Shiomi da Cruz, J.A., Waisberg, D.R., et al. (2014) Lymph Node Distribution in the Central Compartment of the Neck: An Anatomic Study. Head & Neck, 36, 1425-1430.

[25]   College of American Pathologists (2014) College of American Pathologists Cancer Protocols and Checklists.

[26]   Brancato, D., Citarrella, R., Richiusa, P., Amato, M.C., Vetro, C. and Galluzzo, C.G. (2013) Neck Lymph Nodes in Chronic Autoimmune Thyroiditis: The Sonographic Pattern. Thyroid, 23, 173-177.

[27]   Kim, Y.S., Choi, H.J. and Kim, E.S.J. (2013) Papillary Thyroid Carcinoma with Thyroiditis: Lymph Node Metastasis, Complications. Journal of the Korean Surgical Society, 85, 20-24.

[28]   Kim, S.S., Lee, B.J., Lee, J.C., et al. (2011) Coexistence of Hashimoto’s Thyroiditis with Papillary Thyroid Carcinoma: The Influence of Lymph Node Metastasis. Head & Neck, 33, 1272-1277.

[29]   Sahlmann, C.O., Meller, J., Siggelkow, H., et al. (2012) Patients with Autoimmune Thyroiditis. Prevalence of Benign Lymphadenopathy. Nuklearmedizin, 51, 223-227.